Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.
about
Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.Phase variation and microevolution at homopolymeric tracts in Bordetella pertussis.Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains.Bordetella pertussis isolates in Finland: serotype and fimbrial expressionChanges in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift?Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge modelStudies on Prn variation in the mouse model and comparison with epidemiological dataAcellular pertussis vaccines and the role of pertactin and fimbriae.Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.Bordetella pertussis, Finland and France.Effect of vaccination on Bordetella pertussis strains, China.Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussisPertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980-2008).Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.Vaccination and the dynamics of immune evasion.Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000-2012Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007.Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.Multilocus Sequence Analysis of Housekeeping Genes and Antigenic Determinant Genes in Bordetella pertussis Strains Isolated in Korea.Factors contributing to pertussis resurgence.Pertussis in Latin America: current situation and future vaccination challenges.Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran.Bordetella pertussis strain variation and evolution postvaccination.Recent trends of antigenic variation in Bordetella pertussis isolates in Korea.Bordetella pertussis fimbriae (Fim): relevance for vaccines.The characterization of Bordetella pertussis strains isolated in the Central-Western region of Brazil suggests the selection of a specific genetic profile during 2012-2014 outbreaks.Increased risk of pertussis in adult patients with mannose-binding lectin deficiency.Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.
P2860
Q30833407-AB405FE0-3FBD-49A6-BB73-EF371E5DA6A3Q33284950-8D80DF32-1626-48BD-A1AC-F395ACDD4512Q33299470-F206147A-E332-410A-9859-50BEAD3FD6CDQ33371827-279562EA-433C-48B8-B406-FFFE0F018C7DQ33526658-72B814F0-A37C-4A58-A5FB-860B43DC50D0Q33738499-85C21410-3C82-452C-872F-CFCA19916B42Q33825728-54F27300-8295-4035-A55A-C09F63A2E551Q33862635-7F714503-8A1D-4355-AA11-F9774718E63DQ34002283-6E58C47B-ED46-463C-AC83-342B8806736DQ35067167-1263E753-30D2-4A28-B40D-1B83BB3FEAB9Q35801574-74D2FFD3-74C4-47A4-900C-14A6EE232C97Q35804922-9E6FCCA6-A8DC-48F6-A19A-DE035C9D8829Q35964270-746ADFFF-BD45-4F1D-ACF5-B44DB2E0181BQ36277476-CE15AC86-EBCD-407B-A81F-031BCEBADCB7Q36558999-EE122F4B-95D4-469D-9F9A-34403C957372Q36606836-67EF413E-0825-4A70-81F6-65ECE4CB87DCQ36617112-24AB349A-D828-42E0-850D-2E31121956C0Q36673111-FF930B07-9D2A-4E13-AF7A-785A6B105D9BQ37116739-DA25A9AB-E2E4-4537-B541-57DCF94739D6Q37155751-16D63C6D-8300-4FE8-BAA3-EE3D4ABF94E0Q37174125-663D36A8-7D94-4622-8415-132A79B66237Q37340470-E89C2401-7FCA-4E92-9E90-D09CCB0415D0Q37492795-2D53A829-778C-4976-8236-B2C65BF2E0A6Q37524032-F278F645-D7C5-4705-BAF5-2165E07CDD56Q37622182-45FEF929-6DA1-44C4-B0A9-B16EB4C34FEAQ38237862-C0A38549-C4DC-4407-BF38-45A3DA36B5DCQ40325129-D2258A04-3F74-4D94-940F-A58DEEFF9B43Q45172328-C56AC6B7-3287-4D6C-8861-68F9CE1163F9Q53477986-39C0E5DE-D168-4519-AB82-590E4DBEBBF0
P2860
Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Strain variation among Bordete ...... ne has been used for 50 years.
@ast
Strain variation among Bordete ...... ne has been used for 50 years.
@en
Strain variation among Bordete ...... ne has been used for 50 years.
@nl
type
label
Strain variation among Bordete ...... ne has been used for 50 years.
@ast
Strain variation among Bordete ...... ne has been used for 50 years.
@en
Strain variation among Bordete ...... ne has been used for 50 years.
@nl
prefLabel
Strain variation among Bordete ...... ne has been used for 50 years.
@ast
Strain variation among Bordete ...... ne has been used for 50 years.
@en
Strain variation among Bordete ...... ne has been used for 50 years.
@nl
P2093
P2860
P1476
Strain variation among Bordete ...... ne has been used for 50 years.
@en
P2093
Abdolreza Advani
Annika Elomaa
Declan Donnelly
Hans Hallander
Mia Antila
P2860
P304
P356
10.1128/JCM.43.8.3681-3687.2005
P407
P577
2005-08-01T00:00:00Z